Live Breaking News & Updates on மையம் க்கு ப்ரோப் வளர்ச்சி

Stay updated with breaking news from மையம் க்கு ப்ரோப் வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical Manufacturing Facility

CPDC Announces Appointment of Bruno Paquin as Permanent CEO


CPDC Announces Appointment of Bruno Paquin as Permanent CEO
News provided by
Share this article
Share this article
HAMILTON, ON, March 10, 2021 /PRNewswire/ - The Centre for Probe Development and Commercialization (CPDC) announced that its Board of Directors has appointed Bruno Paquin as Chief Executive Officer (CEO). The CEO appointment has taken effect on March 4, 2021. 
Dr. John Thornback, Chair of the Board of Directors said, W
e are pleased to announce that Bruno Paquin has been appointed CEO of CPDC with immediate effect. The Board feels that Bruno has done an excellent job as interim CEO over the past few months and we are looking forward to working with Bruno, and everyone in the CPDC family, our clients and employees, as he leads us through the next phases of development to a successful future. ....

Bruno Paquin , Mcmaster University , Centre For Probe Development , Centre As Senior , Networks Of Centres Excellence , Vp Business Development At Immuni , Ontario Institute For Cancer Research , Business Development , Head Of Business Development , Probe Development , Chief Executive Officer , John Thornback , Senior Director , Technology Development Unit , Genizon Biosciences , Executive Director , Ontario Institute , Cancer Research , Centre For Probe Development And Commercialization , புருனோ ப்யாகயீந் , மக்மாஸ்டர் பல்கலைக்கழகம் , மையம் க்கு ப்ரோப் வளர்ச்சி , மையம் என மூத்தவர் , நெட்வொர்க்குகள் ஆஃப் மையங்கள் சிறப்பானது , ஆஂடேரியொ நிறுவனம் க்கு புற்றுநோய் ஆராய்ச்சி , வணிக வளர்ச்சி ,